William Trattler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
William Trattler has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
Marguerite McDonald
4 shared publicationsParag A. Majmudar
Rush University Medical Center, Chicago
4 shared publicationsAlan Sugar
Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan
3 shared publicationsAyad A. Farjo
Brighton Vision Center, Brighton, Michigan
3 shared publicationsDavid J. Tanzer
Gordon-Weiss-Schanzlin Vision Institute, San Diego, California
3 shared publicationsRajesh K. Rajpal
Avedro, Inc., Waltham, Massachusetts; See Clearly Vision Group, McLean, Virginia
3 shared publications
Latest Publications
- Open Access
- 20 November 2021
- Published by Springer Nature in Ophthalmology and Therapy
- Vol. 11 (1) , 13-14
Correction to: Classification of Presbyopia by Severity
- 20 November 2021
- Published by Springer Nature in Ophthalmology and Therapy
- Vol. 11 (1) , 13-14
Open AccessCorrection to: Classification of Presbyopia by Severity
- Open Access
- 28 October 2021
- Published by Springer Nature in Ophthalmology and Therapy
- Vol. 11 (1) , 1-11
Classification of Presbyopia by Severity
There are close to two billion individuals globally living with presbyopia. In spite of its ubiquitous and progressive nature, there is no widely accepted, formal guideline or consensus statement on the classification of presbyopia by degree of severity. A panel of leading eye care professionals representing both optometrists and ophthalmologists convened virtually to discuss and document their combined assessments from the body of literature and clinical practice expertise in this commentary. In light of emerging therapies, classifying presbyopia by mild, moderate, or advanced severity may help provide consistency of diagnosis among eye care providers and may aid in managing patient expectations with different treatment options.
- 28 October 2021
- Published by Springer Nature in Ophthalmology and Therapy
- Vol. 11 (1) , 1-11
Open AccessClassification of Presbyopia by Severity
There are close to two billion individuals globally living with presbyopia. In spite of its ubiquitous and progressive nature, there is no widely accepted, formal guideline or consensus statement on the classification of presbyopia by degree of severity. A panel of leading eye care professionals representing both optometrists and ophthalmologists convened virtually to discuss and document their combined assessments from the body of literature and clinical practice expertise in this commentary. In light of emerging therapies, classifying presbyopia by mild, moderate, or advanced severity may help provide consistency of diagnosis among eye care providers and may aid in managing patient expectations with different treatment options.
- Top Cited Papers
- 1 September 2017
- Published by Elsevier in Ophthalmology
- Vol. 124 (9) , 1259-1270
United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment
- 1 September 2017
- Published by Elsevier in Ophthalmology
- Vol. 124 (9) , 1259-1270
Top Cited PapersUnited States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment
- Open Access
- 1 August 2017
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 11, 1423-1430
The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye
Purpose: To determine the incidence and severity of dry eye as determined by the International Task Force (ITF) scale in patients being screened for cataract surgery. Patients and methods: This was a prospective, multi-center, observational study of 136 patients, at least 55 years of age, who were scheduled to undergo cataract surgery. The primary outcome measure was the incidence of dry eye as evaluated by grade on the ITF scale and secondary outcome measures include tear break-up time (TBUT), ocular surface disease index score, corneal staining with fluorescein, conjunctival staining with lissamine green, and a patient questionnaire to evaluate symptoms of dry eye. Results: Mean patient age was 70.7 years. A total of 73.5% of patients were Caucasian and 50% were female. Almost 60% had never complained of a foreign body sensation; only 13% complained of a foreign body sensation half or most of the time. The majority of patients (62.9%) had a TBUT ≤5 seconds, 77% of eyes had positive corneal staining and 50% of the eyes had positive central corneal staining. Eighteen percent had Schirmer’s score with anesthesia ≤5 mm. Conclusion: The incidence of dry eye in patients scheduled to undergo cataract surgery in a real-world setting is higher than anticipated.
- 1 August 2017
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 11, 1423-1430
Open AccessThe Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye
Purpose: To determine the incidence and severity of dry eye as determined by the International Task Force (ITF) scale in patients being screened for cataract surgery. Patients and methods: This was a prospective, multi-center, observational study of 136 patients, at least 55 years of age, who were scheduled to undergo cataract surgery. The primary outcome measure was the incidence of dry eye as evaluated by grade on the ITF scale and secondary outcome measures include tear break-up time (TBUT), ocular surface disease index score, corneal staining with fluorescein, conjunctival staining with lissamine green, and a patient questionnaire to evaluate symptoms of dry eye. Results: Mean patient age was 70.7 years. A total of 73.5% of patients were Caucasian and 50% were female. Almost 60% had never complained of a foreign body sensation; only 13% complained of a foreign body sensation half or most of the time. The majority of patients (62.9%) had a TBUT ≤5 seconds, 77% of eyes had positive corneal staining and 50% of the eyes had positive central corneal staining. Eighteen percent had Schirmer’s score with anesthesia ≤5 mm. Conclusion: The incidence of dry eye in patients scheduled to undergo cataract surgery in a real-world setting is higher than anticipated.
- Top Cited PapersOpen Access
- 1 January 2017
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 28 (SUPPLEMENT) , 3-47
Dysfunctional tear syndrome
UNASSIGNED Dysfunctional tear syndrome (DTS) is a common and complex condition affecting the ocular surface. The health and normal functioning of the ocular surface is dependent on a stable and sufficient tear film. Clinician awareness of conditions affecting the ocular surface has increased in recent years because of expanded research and the publication of diagnosis and treatment guidelines pertaining to disorders resulting in DTS, including the Delphi panel treatment recommendations for DTS (2006), the International Dry Eye Workshop (DEWS) (2007), the Meibomian Gland Dysfunction (MGD) Workshop (2011), and the updated Preferred Practice Pattern guidelines from the American Academy of Ophthalmology pertaining to dry eye and blepharitis (2013). Since the publication of the existing guidelines, new diagnostic techniques and treatment options that provide an opportunity for better management of patients have become available. Clinicians are now able to access a wealth of information that can help them obtain a differential diagnosis and treatment approach for patients presenting with DTS. This review provides a practical and directed approach to the diagnosis and treatment of patients with DTS, emphasizing treatment that is tailored to the specific disease subtype as well as the severity of the condition.
- 1 January 2017
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 28 (SUPPLEMENT) , 3-47
Top Cited PapersOpen AccessDysfunctional tear syndrome
UNASSIGNED Dysfunctional tear syndrome (DTS) is a common and complex condition affecting the ocular surface. The health and normal functioning of the ocular surface is dependent on a stable and sufficient tear film. Clinician awareness of conditions affecting the ocular surface has increased in recent years because of expanded research and the publication of diagnosis and treatment guidelines pertaining to disorders resulting in DTS, including the Delphi panel treatment recommendations for DTS (2006), the International Dry Eye Workshop (DEWS) (2007), the Meibomian Gland Dysfunction (MGD) Workshop (2011), and the updated Preferred Practice Pattern guidelines from the American Academy of Ophthalmology pertaining to dry eye and blepharitis (2013). Since the publication of the existing guidelines, new diagnostic techniques and treatment options that provide an opportunity for better management of patients have become available. Clinicians are now able to access a wealth of information that can help them obtain a differential diagnosis and treatment approach for patients presenting with DTS. This review provides a practical and directed approach to the diagnosis and treatment of patients with DTS, emphasizing treatment that is tailored to the specific disease subtype as well as the severity of the condition.
- Open Access
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 41 (10) , 2060-2068
Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies
To evaluate the efficacy and safety of phenylephrine 1.0%-ketorolac 0.3% (Omidria) for maintenance of mydriasis during, and reduction of ocular pain after, cataract surgery. Twenty centers in the United States and the Netherlands. Prospective randomized clinical trials. Patients having cataract surgery or refractive lens exchange were enrolled in 2 clinical trials. Phenylephrine 1.0%-ketorolac 0.3% or placebo was added to irrigation solution and administered intracamerally during the procedure. Integrated analyses of primary and secondary endpoints were conducted. The clinical trials comprised 808 patients (403 treatment and 405 placebo). Phenylephrine 1.0%-ketorolac 0.3% was superior to placebo for the maintenance of mydriasis during, and reduction of ocular pain following, cataract surgery. The mean area under the curve (AUC) change from baseline in pupil diameter was 0.08 mm for treatment compared with -0.50 mm for placebo (P < .0001). The mean AUC of ocular pain visual analog scale scores within 12 hours postoperatively was 4.16 mm for the treatment group and 9.06 mm for the placebo group (P < .001). Results of all secondary efficacy analyses demonstrated a significant treatment effect associated with phenylephrine 1.0%-ketorolac 0.3%. Treatment-emergent adverse events were as expected for a population having cataract surgery; no clinically significant differences in safety measures were observed between treatment groups. In this integrated analysis, phenylephrine 1.0%-ketorolac 0.3% administered intracamerally with irrigation solution during cataract surgery was safe and effective for maintaining mydriasis during the procedure and reducing postoperative ocular pain. Dr. Schaaf is an employee and holds an equity interest in Omeros Corporation. Drs. Hovanesian, Sheppard, Trattler, Gayton, and Ng are consultants to Omeros Corporation. No other author has a financial or proprietary interest in any material or method mentioned.
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 41 (10) , 2060-2068
Open AccessIntracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies
To evaluate the efficacy and safety of phenylephrine 1.0%-ketorolac 0.3% (Omidria) for maintenance of mydriasis during, and reduction of ocular pain after, cataract surgery. Twenty centers in the United States and the Netherlands. Prospective randomized clinical trials. Patients having cataract surgery or refractive lens exchange were enrolled in 2 clinical trials. Phenylephrine 1.0%-ketorolac 0.3% or placebo was added to irrigation solution and administered intracamerally during the procedure. Integrated analyses of primary and secondary endpoints were conducted. The clinical trials comprised 808 patients (403 treatment and 405 placebo). Phenylephrine 1.0%-ketorolac 0.3% was superior to placebo for the maintenance of mydriasis during, and reduction of ocular pain following, cataract surgery. The mean area under the curve (AUC) change from baseline in pupil diameter was 0.08 mm for treatment compared with -0.50 mm for placebo (P < .0001). The mean AUC of ocular pain visual analog scale scores within 12 hours postoperatively was 4.16 mm for the treatment group and 9.06 mm for the placebo group (P < .001). Results of all secondary efficacy analyses demonstrated a significant treatment effect associated with phenylephrine 1.0%-ketorolac 0.3%. Treatment-emergent adverse events were as expected for a population having cataract surgery; no clinically significant differences in safety measures were observed between treatment groups. In this integrated analysis, phenylephrine 1.0%-ketorolac 0.3% administered intracamerally with irrigation solution during cataract surgery was safe and effective for maintaining mydriasis during the procedure and reducing postoperative ocular pain. Dr. Schaaf is an employee and holds an equity interest in Omeros Corporation. Drs. Hovanesian, Sheppard, Trattler, Gayton, and Ng are consultants to Omeros Corporation. No other author has a financial or proprietary interest in any material or method mentioned.
- 1 May 2015
- Published by Wolters Kluwer Health in Cornea
- Vol. 34 (5) , e13-e14
Screening of Refractive Surgery Candidates for LASIK and PRK
- 1 May 2015
- Published by Wolters Kluwer Health in Cornea
- Vol. 34 (5) , e13-e14
Screening of Refractive Surgery Candidates for LASIK and PRK
- 1 March 2015
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 31 (2) , 114-121
Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Keratitis: A Retrospective Safety Surveillance Study
The objective of this study was to collect and evaluate retrospective safety information about the use of besifloxacin ophthalmic suspension 0.6% for the treatment of bacterial keratitis. This was a retrospective, postmarketing surveillance study conducted at 10 clinical centers in the United States. The study population included 142 patients treated with besifloxacin ophthalmic suspension 0.6% for bacterial keratitis in one or both eyes. For perspective, data on 85 patients treated at these centers with moxifloxacin ophthalmic solution 0.5% for bacterial keratitis were also included. The analysis was designed to measure the types and rates of adverse events (AEs) reported during the treatment of bacterial keratitis with besifloxacin ophthalmic suspension 0.6%. Other treatment outcomes of interest included the development of corneal scarring and corneal neovascularization, measured or presumed bacterial eradication, ending visual acuity, and duration of pain before and after treatment. There was one reported AE of mild superficial punctate keratitis in a patient using besifloxacin ophthalmic suspension 0.6%. The difference in AE frequencies between groups was not significant (P>0.999). Additional treatment outcomes were similar for both groups. Limitations of this report include the retrospective nature of the study. These retrospective data suggest that besifloxacin ophthalmic suspension 0.6% was well tolerated when included in the treatment of bacterial keratitis; no serious AEs were reported. A prospective clinical trial is needed to better isolate the contribution of besifloxacin to the therapeutic outcome and to confirm these observations.
- 1 March 2015
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 31 (2) , 114-121
Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Keratitis: A Retrospective Safety Surveillance Study
The objective of this study was to collect and evaluate retrospective safety information about the use of besifloxacin ophthalmic suspension 0.6% for the treatment of bacterial keratitis. This was a retrospective, postmarketing surveillance study conducted at 10 clinical centers in the United States. The study population included 142 patients treated with besifloxacin ophthalmic suspension 0.6% for bacterial keratitis in one or both eyes. For perspective, data on 85 patients treated at these centers with moxifloxacin ophthalmic solution 0.5% for bacterial keratitis were also included. The analysis was designed to measure the types and rates of adverse events (AEs) reported during the treatment of bacterial keratitis with besifloxacin ophthalmic suspension 0.6%. Other treatment outcomes of interest included the development of corneal scarring and corneal neovascularization, measured or presumed bacterial eradication, ending visual acuity, and duration of pain before and after treatment. There was one reported AE of mild superficial punctate keratitis in a patient using besifloxacin ophthalmic suspension 0.6%. The difference in AE frequencies between groups was not significant (P>0.999). Additional treatment outcomes were similar for both groups. Limitations of this report include the retrospective nature of the study. These retrospective data suggest that besifloxacin ophthalmic suspension 0.6% was well tolerated when included in the treatment of bacterial keratitis; no serious AEs were reported. A prospective clinical trial is needed to better isolate the contribution of besifloxacin to the therapeutic outcome and to confirm these observations.
- 1 November 2013
- Published by SLACK, Inc. in Journal of Refractive Surgery
- Vol. 29 (11) , 770-775
Variability of Subjective Classifications of Corneal Topography Maps From LASIK Candidates
PURPOSE: To evaluate the variability of subjective corneal topography map classification between different experienced examiners and the impact of changing from an absolute to a normative scale on the classifications. METHODS: Preoperative axial curvature maps using Scheimpflug imaging obtained with the Pentacam HR (Oculus Optikgeräte, Wetzlar, Germany) and clinical parameters were sent to 11 corneal topography specialists for subjective classification according to the Ectasia Risk Scoring System. The study population included two groups: 11 eyes that developed ectasia after LASIK and 14 eyes that had successful and stable LASIK outcomes. Each case was first reviewed using the absolute scale masked to the patient group. After 3 months, the same cases were represented using a normative scale and reviewed again by the same examiners for new classifications masked to the patient group. RESULTS: Using the absolute scale, 17 of 25 (68%) cases had variations on the classifications from 0 to 4 for the same eye across examiners, and the overall agreement with the mode was 60%. Using the normative scale, the classifications from 11 of 25 (44%) cases varied from 0 to 4 for the same eye across examiners, and the overall agreement with the mode was 61%. Eight examiners (73%) reported statistically higher scores ( P < .05) when using the normative scale. Considering all 550 topographic analyses (25 cases, 11 examiners, and two scales), the same classification from the two scales was reported for 121 case pairs (44%). CONCLUSION: There was significant inter-observer variability in the subjective classifications using the same scale, and significant intra-observer variability between scales. Changing from an absolute to a normative scale increased the scores on the classifications by the same examiner, but significant inter-observer variability in the subjective interpretation of the maps still persisted. [ J Refract Surg. 2013;29(11):770–775.]
- 1 November 2013
- Published by SLACK, Inc. in Journal of Refractive Surgery
- Vol. 29 (11) , 770-775
Variability of Subjective Classifications of Corneal Topography Maps From LASIK Candidates
PURPOSE: To evaluate the variability of subjective corneal topography map classification between different experienced examiners and the impact of changing from an absolute to a normative scale on the classifications. METHODS: Preoperative axial curvature maps using Scheimpflug imaging obtained with the Pentacam HR (Oculus Optikgeräte, Wetzlar, Germany) and clinical parameters were sent to 11 corneal topography specialists for subjective classification according to the Ectasia Risk Scoring System. The study population included two groups: 11 eyes that developed ectasia after LASIK and 14 eyes that had successful and stable LASIK outcomes. Each case was first reviewed using the absolute scale masked to the patient group. After 3 months, the same cases were represented using a normative scale and reviewed again by the same examiners for new classifications masked to the patient group. RESULTS: Using the absolute scale, 17 of 25 (68%) cases had variations on the classifications from 0 to 4 for the same eye across examiners, and the overall agreement with the mode was 60%. Using the normative scale, the classifications from 11 of 25 (44%) cases varied from 0 to 4 for the same eye across examiners, and the overall agreement with the mode was 61%. Eight examiners (73%) reported statistically higher scores ( P < .05) when using the normative scale. Considering all 550 topographic analyses (25 cases, 11 examiners, and two scales), the same classification from the two scales was reported for 121 case pairs (44%). CONCLUSION: There was significant inter-observer variability in the subjective classifications using the same scale, and significant intra-observer variability between scales. Changing from an absolute to a normative scale increased the scores on the classifications by the same examiner, but significant inter-observer variability in the subjective interpretation of the maps still persisted. [ J Refract Surg. 2013;29(11):770–775.]
- Open Access
- 1 October 2013
- Published by SLACK, Inc. in Journal of Refractive Surgery
- Vol. 29 (10) , 666
Pentacam HR Criteria for Curvature Change in Keratoconus and Postoperative LASIK Ectasia
Correspondence Free Roy S. Rubinfeld, MD; Roxanne Littner, MS; William B. Trattler, MD; Karolinne Rocha, MD; Jonathan Talamo, MD; Richard L. Lindstrom, MD Click here to read this article We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas. Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas.1 Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. The study by Epstein et al. analyzes a cumulative data set of patients with keratoconus and postoperative LASIK ectasia and stratifies the variability of measurement accuracy observed based on disease severity. It has also been our experience that the more advanced the ectasia (keratoconus or otherwise), the more variable the metrics produced by corneal topographic and tomographic measurements. Put in statistical terms, the standard error increases with the severity of the disease. Figure 1 is an example of three Pentacam measurements taken of the same eye within minutes of each other. The variation in these three measurements totals 2.4 D. As evident from the image, this patient has rather advanced keratoconus. Figure 1. Kmax reproducibility with Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) for three scans of one eye at the same sitting. Some comments on the statistical methods of Epstein et al.’s study are also in order. The formula for calculating the Rmin COMBO appears to be a harmonic mean over standard deviations, but the authors provide no justification for this weighting. Because this formula is not standard in the statistical literature, justification should be provided. The table appears to confuse the probability of an event with a confidence interval. The authors probably want a tolerance interval for the next observation: that is, constants a,b such that Prob(a ⩽ Y ⩽ b) = 0.95 for the next observation Y. Furthermore, the table appears to be generated by a repeated measures analysis based on unbalanced group sizes, and therefore the authors need to justify computing tail probabilities under these circumstances. Finally, the table appears to test group mean differences, and not individual differences (ie, within-person variation). Given the growing importance of corneal collagen cross-linking and other treatment modalities for keratoconus, continued efforts to optimize measurement accuracy and establish reliable metrics for describing abnormally shaped corneas are valuable. We look forward to more research and debate in this area with the hope and expectation that more universally accepted standard measurement criteria will emerge. Roy S. Rubinfeld, MD Roxanne Littner, MS William B. Trattler, MD Karolinne Rocha, MD Jonathan Talamo, MD Richard L. Lindstrom, MD Waltham, Massachusetts Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We appreciate the praise of our work from these leaders in ophthalmology, and hope that the use of the conclusions of the article may help lead to more rapid diagnosis of the worsening of keratoconus disease and comparison of alternative treatments. The Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) and other Scheimpflug devices allow for analysis of both anterior and posterior corneal curvature. Taking five Pentacam HR measurements rather than one and comparing maximal keratometry reading (Kmax) averages between office visits is a reasonable, current clinical approach. The difference in Kmax average can then be computed manually and the clinician can then use the probability table to determine the likelihood that Kmax actually changed. Determining the likelihood that the cornea has changed using both anterior and posterior measurements is more accurate but less practical in a busy office, but the process is enhanced by software that will hopefully become incorporated directly into the imaging device. Our data revealed that the standard error in Pentacam HR-measured Kmax was uncorrelated with measured Kmax magnitude below measured Kmax of 70 diopters (D). But measurement variability sharply rose at average Kmax of 70 D and these cases were excluded from our statistical study. Whether the rise in Kmax variability at 70 D is machine-related or a problem due to poor patient fixation ability in these worst keratoconus cases is yet to be discovered. The formula for calculating the Rmin COMBO is a weighted average, a linear combination, not a harmonic mean. An alternative expression would be In practice, an unknown true standard deviation (parameter) was estimated by the sample standard deviation. According to Slutsky’s theorem: If Xn → X in distribution and Cn → c (a constant) in probability, then CnXn → cX in distribution. This also holds true for the linear combination CnXn + DnYn → cX + dY. Notice that each of the estimated weights using sample standard deviations is a consistent estimator. The authors believe the application of Slutsky’s theorem was standard in the statistical literature. The table title clearly used the term “probability”; there was no confusion with a “confidence interval” on the authors’ part. A confidence interval was not the intended expression, because a confidence interval is normally established by a give or take number surrounding the sample statistic, which is not a fixed parameter. For the calculation of the probability in the study, if there was no change in the curvature, the difference would truly be fixed at zero. By correctly expressing the value as probability in the table without using the term “confidence interval,” there was no confusion between the probability with a confidence interval. The table was indeed generated by a double repeated measures analysis. The “group size” referred to in the question is the number of repeated measures performed within each individual per visit (old and new). The actual trial dataset contained kold = knew = 5 repeated measures per individual; however, the precision could be derived for numbers other than 5 for each of the two visits, to help physicians understand the loss of precision, from the convenience gained by taking fewer repeated measures (kold or knew < 5). Using the within-subject variance estimate from the double-repeated measures analysis, the formula for the precision calculation (standard error) is: To further illustrate additional scenarios with additional values for kold + knew from 1 + 1 to 5 + 5, see Figure 1, which did not appear in the article. For the study, the tail probabilities were then generated using the normal approximation. The practice above was also considered standard by the authors in the statistical literature for repeated measures analysis. As explained above, the differences were “within-person” because k repeated measures were performed within an individual per visit. Robert L. Epstein, MD Yi-Lin Chiu, PhD Greg Epstein, BS McHenry, Illinois Figure 1. Kmax reproducibility with Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) for three scans of one eye at the same sitting. 10.3928/1081597X-20130919-02 Click here to read this article We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas. Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. Click here to read this article We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas. Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas.1 Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. The study by Epstein et al. analyzes a cumulative data set of patients with keratoconus and postoperative LASIK ectasia and stratifies the variability of measurement accuracy observed based on disease severity. It has also been our experience that the more advanced the ectasia (keratoconus or otherwise), the more variable the metrics produced by corneal topographic and tomographic measurements. Put in statistical terms, the standard error increases with the severity of the disease. Figure 1 is an example of three Pentacam measurements taken of the same eye within minutes of each other. The variation in these three measurements totals 2.4 D. As evident from the image, this patient has rather advanced keratoconus. Figure 1. Kmax reproducibility with Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) for three scans of one eye at the same sitting. Some comments on the statistical methods of Epstein et al.’s study are also in order. The formula for calculating the Rmin COMBO appears to be a harmonic mean over standard deviations, but the authors provide no justification for this weighting. Because this formula is not standard in the statistical literature, justification should be provided. The table appears to confuse the probability of an event with a confidence interval. The authors probably want a tolerance interval for the next observation: that is, constants a,b such that Prob(a ⩽ Y ⩽ b) = 0.95 for the next observation Y. Furthermore, the table appears to be generated by a repeated measures analysis based on unbalanced group sizes, and therefore the authors need to justify computing tail probabilities under these circumstances. Finally, the table appears to test group mean differences, and not individual differences (ie, within-person variation). Given the growing importance of corneal collagen cross-linking and other treatment modalities for keratoconus, continued efforts to optimize measurement accuracy and establish reliable metrics for describing abnormally shaped corneas are valuable. We look forward to more research and debate in this area with the hope and expectation that more universally accepted standard measurement criteria will emerge. Roy S. Rubinfeld, MD Roxanne Littner, MS William B. Trattler, MD Karolinne Rocha, MD Jonathan Talamo, MD Richard L. Lindstrom, MD Waltham, Massachusetts Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We appreciate the praise of our work from these leaders in ophthalmology, and hope that the use of the conclusions of the article may help lead to more rapid diagnosis of the worsening of keratoconus disease and comparison of alternative treatments. The Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) and other Scheimpflug devices allow for analysis of both anterior and posterior corneal curvature. Taking five Pentacam HR measurements rather than one and comparing maximal keratometry reading (Kmax) averages between office visits is a reasonable, current clinical approach. The difference in Kmax average can then be computed manually and the clinician can then use the probability table to determine the likelihood that Kmax actually changed. Determining the likelihood that the cornea has changed using both anterior and posterior measurements is more accurate but less practical in a busy office, but the process is enhanced by software that will hopefully become incorporated directly into the imaging device. Our data revealed that the standard error in Pentacam HR-measured Kmax was uncorrelated with measured Kmax magnitude below measured Kmax of 70 diopters (D). But measurement variability sharply rose at average Kmax of 70 D and these cases were excluded from our statistical study. Whether the rise in Kmax variability at 70 D is machine-related or a problem due to poor patient fixation ability in these worst keratoconus cases is yet to be discovered. The formula for calculating the Rmin COMBO is a weighted average, a linear combination, not a harmonic mean. An alternative expression would be In practice, an unknown true standard deviation (parameter) was estimated by the sample standard deviation. According to Slutsky’s theorem: If Xn → X in distribution and Cn → c (a constant) in probability, then CnXn → cX in distribution. This also holds true for the linear combination CnXn + DnYn → cX + dY. Notice that each of the estimated weights using sample standard deviations is a consistent estimator. The authors believe the application of Slutsky’s theorem was standard in the statistical literature. The table title clearly used the term “probability”; there was no confusion with a “confidence interval” on the authors’ part. A confidence interval was not the intended expression, because a confidence interval is normally established by a give or take number surrounding the sample statistic, which is not a fixed parameter. For the calculation of the probability in the study, if there was no change in the curvature, the difference would truly be fixed at zero. By correctly expressing the value as probability in the table without using the term “confidence interval,” there was no confusion between the probability with a confidence interval. The table was indeed generated by a double repeated measures analysis. The “group size” referred to in the question is the number of repeated measures performed within each individual per visit (old and new). The actual trial dataset contained kold = knew = 5 repeated measures per individual; however, the precision could be derived for numbers other than 5 for each of the two visits, to help physicians understand the loss of precision, from the convenience gained by taking fewer repeated measures (kold or knew < 5). Using the within-subject variance estimate from the double-repeated measures analysis, the formula for the precision calculation (standard error) is: To further illustrate additional scenarios with additional values for kold + knew from 1 + 1 to 5 + 5, see Figure 1, which did not appear in the article. For the study, the tail probabilities were then generated using the normal approximation. The practice above was also considered standard by the authors in the statistical literature for repeated measures analysis. As explained above, the...
- 1 October 2013
- Published by SLACK, Inc. in Journal of Refractive Surgery
- Vol. 29 (10) , 666
Open AccessPentacam HR Criteria for Curvature Change in Keratoconus and Postoperative LASIK Ectasia
Correspondence Free Roy S. Rubinfeld, MD; Roxanne Littner, MS; William B. Trattler, MD; Karolinne Rocha, MD; Jonathan Talamo, MD; Richard L. Lindstrom, MD Click here to read this article We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas. Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas.1 Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. The study by Epstein et al. analyzes a cumulative data set of patients with keratoconus and postoperative LASIK ectasia and stratifies the variability of measurement accuracy observed based on disease severity. It has also been our experience that the more advanced the ectasia (keratoconus or otherwise), the more variable the metrics produced by corneal topographic and tomographic measurements. Put in statistical terms, the standard error increases with the severity of the disease. Figure 1 is an example of three Pentacam measurements taken of the same eye within minutes of each other. The variation in these three measurements totals 2.4 D. As evident from the image, this patient has rather advanced keratoconus. Figure 1. Kmax reproducibility with Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) for three scans of one eye at the same sitting. Some comments on the statistical methods of Epstein et al.’s study are also in order. The formula for calculating the Rmin COMBO appears to be a harmonic mean over standard deviations, but the authors provide no justification for this weighting. Because this formula is not standard in the statistical literature, justification should be provided. The table appears to confuse the probability of an event with a confidence interval. The authors probably want a tolerance interval for the next observation: that is, constants a,b such that Prob(a ⩽ Y ⩽ b) = 0.95 for the next observation Y. Furthermore, the table appears to be generated by a repeated measures analysis based on unbalanced group sizes, and therefore the authors need to justify computing tail probabilities under these circumstances. Finally, the table appears to test group mean differences, and not individual differences (ie, within-person variation). Given the growing importance of corneal collagen cross-linking and other treatment modalities for keratoconus, continued efforts to optimize measurement accuracy and establish reliable metrics for describing abnormally shaped corneas are valuable. We look forward to more research and debate in this area with the hope and expectation that more universally accepted standard measurement criteria will emerge. Roy S. Rubinfeld, MD Roxanne Littner, MS William B. Trattler, MD Karolinne Rocha, MD Jonathan Talamo, MD Richard L. Lindstrom, MD Waltham, Massachusetts Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We appreciate the praise of our work from these leaders in ophthalmology, and hope that the use of the conclusions of the article may help lead to more rapid diagnosis of the worsening of keratoconus disease and comparison of alternative treatments. The Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) and other Scheimpflug devices allow for analysis of both anterior and posterior corneal curvature. Taking five Pentacam HR measurements rather than one and comparing maximal keratometry reading (Kmax) averages between office visits is a reasonable, current clinical approach. The difference in Kmax average can then be computed manually and the clinician can then use the probability table to determine the likelihood that Kmax actually changed. Determining the likelihood that the cornea has changed using both anterior and posterior measurements is more accurate but less practical in a busy office, but the process is enhanced by software that will hopefully become incorporated directly into the imaging device. Our data revealed that the standard error in Pentacam HR-measured Kmax was uncorrelated with measured Kmax magnitude below measured Kmax of 70 diopters (D). But measurement variability sharply rose at average Kmax of 70 D and these cases were excluded from our statistical study. Whether the rise in Kmax variability at 70 D is machine-related or a problem due to poor patient fixation ability in these worst keratoconus cases is yet to be discovered. The formula for calculating the Rmin COMBO is a weighted average, a linear combination, not a harmonic mean. An alternative expression would be In practice, an unknown true standard deviation (parameter) was estimated by the sample standard deviation. According to Slutsky’s theorem: If Xn → X in distribution and Cn → c (a constant) in probability, then CnXn → cX in distribution. This also holds true for the linear combination CnXn + DnYn → cX + dY. Notice that each of the estimated weights using sample standard deviations is a consistent estimator. The authors believe the application of Slutsky’s theorem was standard in the statistical literature. The table title clearly used the term “probability”; there was no confusion with a “confidence interval” on the authors’ part. A confidence interval was not the intended expression, because a confidence interval is normally established by a give or take number surrounding the sample statistic, which is not a fixed parameter. For the calculation of the probability in the study, if there was no change in the curvature, the difference would truly be fixed at zero. By correctly expressing the value as probability in the table without using the term “confidence interval,” there was no confusion between the probability with a confidence interval. The table was indeed generated by a double repeated measures analysis. The “group size” referred to in the question is the number of repeated measures performed within each individual per visit (old and new). The actual trial dataset contained kold = knew = 5 repeated measures per individual; however, the precision could be derived for numbers other than 5 for each of the two visits, to help physicians understand the loss of precision, from the convenience gained by taking fewer repeated measures (kold or knew < 5). Using the within-subject variance estimate from the double-repeated measures analysis, the formula for the precision calculation (standard error) is: To further illustrate additional scenarios with additional values for kold + knew from 1 + 1 to 5 + 5, see Figure 1, which did not appear in the article. For the study, the tail probabilities were then generated using the normal approximation. The practice above was also considered standard by the authors in the statistical literature for repeated measures analysis. As explained above, the differences were “within-person” because k repeated measures were performed within an individual per visit. Robert L. Epstein, MD Yi-Lin Chiu, PhD Greg Epstein, BS McHenry, Illinois Figure 1. Kmax reproducibility with Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) for three scans of one eye at the same sitting. 10.3928/1081597X-20130919-02 Click here to read this article We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas. Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. Click here to read this article We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas. Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We read with great interest the important study by Epstein et al. describing the significant variability in corneal curvature measurements in patients with ectatic corneas.1 Even when using a modern, advanced imager (Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar, Germany), single measurements with 95% confidence interval of a true change in ΔKmax were 1.51 diopters (D). Repeated measurements in the study by Epstein et al. reduced that to 0.68 D. The authors proposed criteria involving multiple measurements in future studies analyzing the results of collagen cross-linking. We commend Epstein et al. on their work, which serves the dual purposes of establishing measurement criteria for gauging the magnitude of effect delivered by medical and surgical treatments of ectatic corneas and initiating a discussion on the relationship between severity of corneal ectasia and our ability to accurately and consistently measure these corneas. The study by Epstein et al. analyzes a cumulative data set of patients with keratoconus and postoperative LASIK ectasia and stratifies the variability of measurement accuracy observed based on disease severity. It has also been our experience that the more advanced the ectasia (keratoconus or otherwise), the more variable the metrics produced by corneal topographic and tomographic measurements. Put in statistical terms, the standard error increases with the severity of the disease. Figure 1 is an example of three Pentacam measurements taken of the same eye within minutes of each other. The variation in these three measurements totals 2.4 D. As evident from the image, this patient has rather advanced keratoconus. Figure 1. Kmax reproducibility with Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) for three scans of one eye at the same sitting. Some comments on the statistical methods of Epstein et al.’s study are also in order. The formula for calculating the Rmin COMBO appears to be a harmonic mean over standard deviations, but the authors provide no justification for this weighting. Because this formula is not standard in the statistical literature, justification should be provided. The table appears to confuse the probability of an event with a confidence interval. The authors probably want a tolerance interval for the next observation: that is, constants a,b such that Prob(a ⩽ Y ⩽ b) = 0.95 for the next observation Y. Furthermore, the table appears to be generated by a repeated measures analysis based on unbalanced group sizes, and therefore the authors need to justify computing tail probabilities under these circumstances. Finally, the table appears to test group mean differences, and not individual differences (ie, within-person variation). Given the growing importance of corneal collagen cross-linking and other treatment modalities for keratoconus, continued efforts to optimize measurement accuracy and establish reliable metrics for describing abnormally shaped corneas are valuable. We look forward to more research and debate in this area with the hope and expectation that more universally accepted standard measurement criteria will emerge. Roy S. Rubinfeld, MD Roxanne Littner, MS William B. Trattler, MD Karolinne Rocha, MD Jonathan Talamo, MD Richard L. Lindstrom, MD Waltham, Massachusetts Drs. Rubinfeld, Littner, Trattler, Rocha, Talamo, and Lindstrom are consultants for and Drs. Rubinfeld, Littner, Trattler, Talamo, and Lindstrom are stockholders in CXL Ophthalmics, Encinitas, California. We appreciate the praise of our work from these leaders in ophthalmology, and hope that the use of the conclusions of the article may help lead to more rapid diagnosis of the worsening of keratoconus disease and comparison of alternative treatments. The Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) and other Scheimpflug devices allow for analysis of both anterior and posterior corneal curvature. Taking five Pentacam HR measurements rather than one and comparing maximal keratometry reading (Kmax) averages between office visits is a reasonable, current clinical approach. The difference in Kmax average can then be computed manually and the clinician can then use the probability table to determine the likelihood that Kmax actually changed. Determining the likelihood that the cornea has changed using both anterior and posterior measurements is more accurate but less practical in a busy office, but the process is enhanced by software that will hopefully become incorporated directly into the imaging device. Our data revealed that the standard error in Pentacam HR-measured Kmax was uncorrelated with measured Kmax magnitude below measured Kmax of 70 diopters (D). But measurement variability sharply rose at average Kmax of 70 D and these cases were excluded from our statistical study. Whether the rise in Kmax variability at 70 D is machine-related or a problem due to poor patient fixation ability in these worst keratoconus cases is yet to be discovered. The formula for calculating the Rmin COMBO is a weighted average, a linear combination, not a harmonic mean. An alternative expression would be In practice, an unknown true standard deviation (parameter) was estimated by the sample standard deviation. According to Slutsky’s theorem: If Xn → X in distribution and Cn → c (a constant) in probability, then CnXn → cX in distribution. This also holds true for the linear combination CnXn + DnYn → cX + dY. Notice that each of the estimated weights using sample standard deviations is a consistent estimator. The authors believe the application of Slutsky’s theorem was standard in the statistical literature. The table title clearly used the term “probability”; there was no confusion with a “confidence interval” on the authors’ part. A confidence interval was not the intended expression, because a confidence interval is normally established by a give or take number surrounding the sample statistic, which is not a fixed parameter. For the calculation of the probability in the study, if there was no change in the curvature, the difference would truly be fixed at zero. By correctly expressing the value as probability in the table without using the term “confidence interval,” there was no confusion between the probability with a confidence interval. The table was indeed generated by a double repeated measures analysis. The “group size” referred to in the question is the number of repeated measures performed within each individual per visit (old and new). The actual trial dataset contained kold = knew = 5 repeated measures per individual; however, the precision could be derived for numbers other than 5 for each of the two visits, to help physicians understand the loss of precision, from the convenience gained by taking fewer repeated measures (kold or knew < 5). Using the within-subject variance estimate from the double-repeated measures analysis, the formula for the precision calculation (standard error) is: To further illustrate additional scenarios with additional values for kold + knew from 1 + 1 to 5 + 5, see Figure 1, which did not appear in the article. For the study, the tail probabilities were then generated using the normal approximation. The practice above was also considered standard by the authors in the statistical literature for repeated measures analysis. As explained above, the...